Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells

A hallmark of advanced prostate cancer (PC) is the concomitant loss of PTEN and p53 function. To selectively eliminate such cells, we screened cytotoxic compounds on Pten(−/−);Trp53(−/−) fibroblasts and their Pten-WT reference. Highly selective killing of Pten-null cells can be achieved by deguelin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Naguib, Adam, Mathew, Grinu, Reczek, Colleen R., Watrud, Kaitlin, Ambrico, Alexandra, Herzka, Tali, Salas, Irene Casanova, Lee, Matthew F., El-Amine, Nour, Zheng, Wu, Di Francesco, M. Emilia, Marszalek, Joseph R., Pappin, Darryl J., Chandel, Navdeep S., Trotman, Lloyd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003704/
https://www.ncbi.nlm.nih.gov/pubmed/29617673
http://dx.doi.org/10.1016/j.celrep.2018.03.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003704/
https://www.ncbi.nlm.nih.gov/pubmed/29617673
http://dx.doi.org/10.1016/j.celrep.2018.03.032

Ejemplares similares